Pesqué, D, Planella-Fontanillas, N, Borrego, L, Sanz-Sánchez, T, Zaragoza-Ninet, V, Serra-Baldrich, E, Miquel-Miquel, FJ, Silvestre-Salvador, JF, Córdoba-Guijarro, S, Sánchez-Gilo, A, Mercader-García, P, Navarro-Triviño, FJ, Ortiz-de-Frutos, FJ, Tous-Romero, F, Rodríguez-Serna, M, Melé-Ninot, G, Barrabés-Torrella, C, Ruiz-González, I, Pastor-Nieto, MA, Carrascosa-Carrillo, JM, Gómez-de-la-Fuente, E, Sánchez-Pedreño-Guillén, P, Sánchez-Pérez, J, Pereyra-Rodríguez, JJ, Gatica-Ortega, ME, González-Pérez, R, Pujol, RM, Descalzo, MAG, García-Doval, I, Giménez-Arnau, AM. Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023. CONTACT DERMATITIS. 2025; 92(2)DOI:10.1111/cod.14702. PMID:39394969. IF:4.600(Q1/1D).

Mateu-Arrom, L, Yélamos, O, Morales-Munera, CE. Refractory Lichen Sclerosus Treated With Fractional CO2 Laser-assisted Drug Delivery Photodynamic Therapy Using 5-Aminolevulinic Acid: A Case Series. Actas Dermo-Sifiliograficas. 2025; 116(2)DOI:10.1016/j.ad.2024.09.017. PMID:39419378. IF:(Q/D).

Morales-Múnera, CE, Montoya, F, de Loredo, N, Sendagorta, E. AEDV Expert Document on the Management of Ulcerative Venereal Infections. Actas Dermo-Sifiliograficas. 2025; 116(2)DOI:10.1016/j.ad.2024.11.012. PMID:39566736. IF:(Q/D).

Martorell-Calatayud, A, Santos-Alarcón, S, Sahuquillo-Torralba, A, Rivera-Díaz, R, Belinchón-Romero, I, Ruiz-Genao, D, Romero-Maté, A, Ruiz-Villaverde, R, Ferran-Farrés, M, Gallardo-Hernández, F, Almenara-Blasco, M, Suarez-Perez, JA, González-Cantero, A, Martínez-Lorenzo, E, Fernández-Armenteros, JM, del Alcázar-Viladomiu, E, García-Latasa, J, Rocamora-Durant, V, Ara-Martín, M, Mateu-Puchades, A, Llamas-Velasco, M, Vilarrasa, E, Velasco-Pastor, M, De la Cueva, P, Carrascosa, JM, Magdaleno-Tapial, J. Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study. Actas Dermo-Sifiliograficas. 2025; 116(2)DOI:10.1016/j.ad.2024.02.030. PMID:38452889. IF:(Q/D).

Mateu-Arrom, L, Giménez-Arnau, AM, Expósito-Serrano, V, Bonfill-Orti, M, Serra-Baldrich, E, Yélamos, O, Spertino, J. Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2025; 64(1)DOI:10.1111/ijd.17358. PMID:38940007. IF:3.200(Q1/3D).

Cerezuela-Fuentes, P, Gonzalez-Cao, M, Puertolas, T, Manzano, JL, Maldonado, C, Yelamos, O, Berciano-Guerrero, MA, Martin-Liberal, J, Muñoz-Couselo, E, Espinosa, E, Drozdowskyj, A, Berrocal, A, Soria, A, Marquez-Rodas, I, Martin-Algarra, S, Quindos, M, Puig, S. Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis. Clinical & Translational Oncology. 2025; 27(1)DOI:10.1007/s12094-024-03583-5. PMID:38951438. IF:2.500(Q3/6D).

Torres, T, Brembilla, NC, Langley, RG, Warren, RB, Thaci, D, Kolios, AGA, Prinz, JC, Londono-Garcia, A, Nast, A, Santin, M, Goletti, D, Abreu, M, Spuls, P, Boehncke, WH, Puig, L. Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(1)DOI:10.1111/jdv.20287. PMID:39149807. IF:8.000(Q1/1D).

Carmona-Rocha, E, Rusiñol, L, Puig, L. Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology. Pharmaceutics. 2025; 17(1)DOI:10.3390/pharmaceutics17010091. PMID:39861739. IF:5.500(Q1/1D).